Annual revenue:
$2.76B+$259.10M(+10.37%)Summary
- As of today (May 6, 2025), EXAS annual revenue is $2.76 billion, with the most recent change of +$259.10 million (+10.37%) on December 31, 2024.
- During the last 3 years, EXAS annual revenue has risen by +$991.78 million (+56.13%).
- EXAS annual revenue is now at all-time high.
Performance
EXAS Revenue Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Quarterly revenue:
$706.78M-$6.64M(-0.93%)Summary
- As of today (May 6, 2025), EXAS quarterly revenue is $706.78 million, with the most recent change of -$6.64 million (-0.93%) on March 31, 2025.
- Over the past year, EXAS quarterly revenue has increased by +$69.26 million (+10.86%).
- EXAS quarterly revenue is now -0.93% below its all-time high of $713.42 million, reached on December 31, 2024.
Performance
EXAS Quarterly revenue Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM revenue:
$2.83B+$69.26M(+2.51%)Summary
- As of today (May 6, 2025), EXAS TTM revenue is $2.83 billion, with the most recent change of +$69.26 million (+2.51%) on March 31, 2025.
- Over the past year, EXAS TTM revenue has increased by +$293.29 million (+11.57%).
- EXAS TTM revenue is now at all-time high.
Performance
EXAS TTM revenue Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
EXAS Revenue Trends
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
---|---|---|---|
1 y1 year | +10.4% | +10.9% | +11.6% |
3 y3 years | +56.1% | +45.3% | +52.7% |
5 y5 years | +214.8% | +103.2% | +166.3% |
EXAS Revenue Highs & Lows
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
---|---|---|---|---|---|---|---|
3 y | 3-year | at high | +56.1% | -0.9% | +45.3% | at high | +52.7% |
5 y | 5-year | at high | +214.8% | -0.9% | +162.9% | at high | +166.3% |
alltime | all time | at high | >+9999.0% | -0.9% | >+9999.0% | at high | >+9999.0% |
Exact Sciences Revenue History
Date | Annual | Quarterly | TTM |
---|---|---|---|
Mar 2025 | - | $706.78M(-0.9%) | $2.83B(+2.5%) |
Dec 2024 | $2.76B(+10.4%) | $713.42M(+0.7%) | $2.76B(+2.5%) |
Sep 2024 | - | $708.65M(+1.3%) | $2.69B(+3.1%) |
Jun 2024 | - | $699.26M(+9.7%) | $2.61B(+3.0%) |
Mar 2024 | - | $637.52M(-1.4%) | $2.53B(+1.4%) |
Dec 2023 | $2.50B(+19.9%) | $646.88M(+3.0%) | $2.50B(+3.9%) |
Sep 2023 | - | $628.34M(+1.0%) | $2.41B(+4.6%) |
Jun 2023 | - | $622.09M(+3.3%) | $2.30B(+4.6%) |
Mar 2023 | - | $602.45M(+8.9%) | $2.20B(+5.6%) |
Dec 2022 | $2.08B(+17.9%) | $553.00M(+5.7%) | $2.08B(+3.9%) |
Sep 2022 | - | $523.07M(+0.3%) | $2.01B(+3.4%) |
Jun 2022 | - | $521.64M(+7.2%) | $1.94B(+4.7%) |
Mar 2022 | - | $486.57M(+2.7%) | $1.85B(+4.8%) |
Dec 2021 | $1.77B(+18.5%) | $473.81M(+3.8%) | $1.77B(+0.4%) |
Sep 2021 | - | $456.38M(+5.0%) | $1.76B(+2.8%) |
Jun 2021 | - | $434.82M(+8.1%) | $1.71B(+10.7%) |
Mar 2021 | - | $402.08M(-13.8%) | $1.55B(+3.6%) |
Dec 2020 | $1.49B(+70.2%) | $466.34M(+14.2%) | $1.49B(+12.9%) |
Sep 2020 | - | $408.36M(+51.9%) | $1.32B(+16.8%) |
Jun 2020 | - | $268.87M(-22.7%) | $1.13B(+6.5%) |
Mar 2020 | - | $347.82M(+17.7%) | $1.06B(+21.2%) |
Dec 2019 | $876.29M(+92.8%) | $295.57M(+35.1%) | $876.29M(+21.1%) |
Sep 2019 | - | $218.81M(+9.5%) | $723.70M(+16.1%) |
Jun 2019 | - | $199.87M(+23.3%) | $623.18M(+18.4%) |
Mar 2019 | - | $162.04M(+13.3%) | $526.21M(+15.8%) |
Dec 2018 | $454.46M(+70.9%) | $142.98M(+20.9%) | $454.46M(+13.9%) |
Sep 2018 | - | $118.29M(+15.0%) | $398.89M(+12.9%) |
Jun 2018 | - | $102.89M(+14.0%) | $353.17M(+14.7%) |
Mar 2018 | - | $90.30M(+3.3%) | $307.92M(+15.8%) |
Dec 2017 | $265.99M(+167.7%) | $87.41M(+20.4%) | $265.99M(+24.4%) |
Sep 2017 | - | $72.57M(+25.9%) | $213.82M(+26.3%) |
Jun 2017 | - | $57.65M(+19.2%) | $169.37M(+27.4%) |
Mar 2017 | - | $48.36M(+37.2%) | $132.90M(+33.7%) |
Dec 2016 | $99.38M(+152.0%) | $35.24M(+25.3%) | $99.38M(+26.5%) |
Sep 2016 | - | $28.11M(+32.7%) | $78.56M(+24.5%) |
Jun 2016 | - | $21.18M(+42.8%) | $63.07M(+26.1%) |
Mar 2016 | - | $14.84M(+2.9%) | $50.01M(+26.8%) |
Dec 2015 | $39.44M(+2093.4%) | $14.42M(+14.2%) | $39.44M(+48.7%) |
Sep 2015 | - | $12.63M(+55.6%) | $26.52M(+90.9%) |
Jun 2015 | - | $8.12M(+90.3%) | $13.89M(+140.7%) |
Mar 2015 | - | $4.27M(+183.6%) | $5.77M(+220.9%) |
Dec 2014 | $1.80M(-56.6%) | $1.50M(+411.6%) | $1.80M(-47.1%) |
Mar 2014 | - | $294.00K(-71.6%) | $3.40M(-17.9%) |
Dec 2013 | $4.14M(0.0%) | $1.04M(0.0%) | $4.14M(0.0%) |
Sep 2013 | - | $1.04M(0.0%) | $4.14M(0.0%) |
Jun 2013 | - | $1.04M(0.0%) | $4.14M(0.0%) |
Mar 2013 | - | $1.04M(0.0%) | $4.14M(0.0%) |
Date | Annual | Quarterly | TTM |
---|---|---|---|
Dec 2012 | $4.14M(-0.5%) | $1.04M(0.0%) | $4.14M(-0.1%) |
Sep 2012 | - | $1.04M(0.0%) | $4.15M(-0.1%) |
Jun 2012 | - | $1.04M(0.0%) | $4.15M(-0.1%) |
Mar 2012 | - | $1.04M(-0.6%) | $4.16M(-0.1%) |
Dec 2011 | $4.16M(-22.1%) | $1.04M(+0.3%) | $4.16M(-7.4%) |
Sep 2011 | - | $1.04M(-0.3%) | $4.50M(-6.6%) |
Jun 2011 | - | $1.04M(+0.2%) | $4.81M(-5.3%) |
Mar 2011 | - | $1.04M(-24.4%) | $5.08M(-4.8%) |
Dec 2010 | $5.34M(+12.3%) | $1.38M(+1.4%) | $5.34M(+2.5%) |
Sep 2010 | - | $1.36M(+3.2%) | $5.21M(+2.0%) |
Jun 2010 | - | $1.31M(+1.2%) | $5.11M(+1.1%) |
Mar 2010 | - | $1.30M(+4.4%) | $5.06M(+6.3%) |
Dec 2009 | $4.76M(-648.8%) | $1.24M(-1.0%) | $4.76M(+194.1%) |
Sep 2009 | - | $1.26M(-0.2%) | $1.62M(+131.5%) |
Jun 2009 | - | $1.26M(+25.8%) | $699.00K(-225.0%) |
Mar 2009 | - | $1.00M(-152.7%) | -$559.00K(-62.9%) |
Dec 2008 | -$867.00K(-129.5%) | -$1.90M(-662.6%) | -$1.51M(-263.0%) |
Sep 2008 | - | $337.00K(+560.8%) | $925.00K(-49.1%) |
Mar 2008 | - | $51.00K(-90.5%) | $1.82M(-38.1%) |
Dec 2007 | $2.94M(-38.2%) | $537.00K(+375.2%) | $2.94M(-18.0%) |
Sep 2007 | - | $113.00K(-89.9%) | $3.58M(-22.6%) |
Jun 2007 | - | $1.11M(-4.7%) | $4.62M(-2.2%) |
Mar 2007 | - | $1.17M(-0.8%) | $4.73M(-0.5%) |
Dec 2006 | $4.75M(+11.8%) | $1.18M(+2.2%) | $4.75M(-0.1%) |
Sep 2006 | - | $1.16M(-5.4%) | $4.75M(-0.8%) |
Jun 2006 | - | $1.22M(+2.3%) | $4.79M(+14.2%) |
Mar 2006 | - | $1.19M(+0.8%) | $4.20M(-1.2%) |
Dec 2005 | $4.25M(-13.9%) | $1.19M(-0.8%) | $4.25M(-2.1%) |
Sep 2005 | - | $1.20M(+91.8%) | $4.34M(-1.5%) |
Jun 2005 | - | $623.00K(-50.0%) | $4.41M(-12.0%) |
Mar 2005 | - | $1.25M(-2.2%) | $5.00M(+1.4%) |
Dec 2004 | $4.93M(+70.1%) | $1.27M(+1.1%) | $4.93M(+2.2%) |
Sep 2004 | - | $1.26M(+3.2%) | $4.83M(+7.6%) |
Jun 2004 | - | $1.22M(+3.8%) | $4.49M(+22.2%) |
Mar 2004 | - | $1.18M(+0.7%) | $3.67M(+26.5%) |
Dec 2003 | $2.90M(+223.4%) | $1.17M(+27.3%) | $2.90M(+35.5%) |
Sep 2003 | - | $918.00K(+126.1%) | $2.14M(+31.2%) |
Jun 2003 | - | $406.00K(-0.5%) | $1.63M(+28.9%) |
Mar 2003 | - | $408.00K(-0.1%) | $1.27M(+41.1%) |
Dec 2002 | $897.00K(+1658.8%) | $408.30K(-0.3%) | $897.10K(+70.3%) |
Sep 2002 | - | $409.50K(+923.8%) | $526.70K(+304.2%) |
Jun 2002 | - | $40.00K(+1.8%) | $130.30K(+44.3%) |
Mar 2002 | - | $39.30K(+3.7%) | $90.30K(+77.1%) |
Dec 2001 | $51.00K | $37.90K(+189.3%) | $51.00K(+289.3%) |
Sep 2001 | - | $13.10K(>+9900.0%) | $13.10K(>+9900.0%) |
Jun 2001 | - | $0.00(0.0%) | $0.00(0.0%) |
Mar 2001 | - | $0.00 | $0.00 |
FAQ
- What is Exact Sciences annual revenue?
- What is the all time high annual revenue for Exact Sciences?
- What is Exact Sciences annual revenue year-on-year change?
- What is Exact Sciences quarterly revenue?
- What is the all time high quarterly revenue for Exact Sciences?
- What is Exact Sciences quarterly revenue year-on-year change?
- What is Exact Sciences TTM revenue?
- What is the all time high TTM revenue for Exact Sciences?
- What is Exact Sciences TTM revenue year-on-year change?
What is Exact Sciences annual revenue?
The current annual revenue of EXAS is $2.76B
What is the all time high annual revenue for Exact Sciences?
Exact Sciences all-time high annual revenue is $2.76B
What is Exact Sciences annual revenue year-on-year change?
Over the past year, EXAS annual revenue has changed by +$259.10M (+10.37%)
What is Exact Sciences quarterly revenue?
The current quarterly revenue of EXAS is $706.78M
What is the all time high quarterly revenue for Exact Sciences?
Exact Sciences all-time high quarterly revenue is $713.42M
What is Exact Sciences quarterly revenue year-on-year change?
Over the past year, EXAS quarterly revenue has changed by +$69.26M (+10.86%)
What is Exact Sciences TTM revenue?
The current TTM revenue of EXAS is $2.83B
What is the all time high TTM revenue for Exact Sciences?
Exact Sciences all-time high TTM revenue is $2.83B
What is Exact Sciences TTM revenue year-on-year change?
Over the past year, EXAS TTM revenue has changed by +$293.29M (+11.57%)